Abigail Bracha

Abigail Bracha serves as Senior Vice President of Corporate Strategy & Business Development at Clover. Prior to Clover, Ms. Bracha held leadership positions at Candel Therapeutics and Rubius Therapeutics where she led corporate development. Earlier in her career, Ms. Bracha founded and led the global strategy, search, and evaluation team for GE Healthcare Life Sciences, where she developed the growth strategy and technology innovation roadmap for GE’s life sciences tools business. Prior to GE Healthcare, Abigail worked at GE Ventures.

Abigail Bracha completed a Ph.D. from Harvard University in Experimental Pathology and a Bachelor of Arts in Statistics with General Honors from the University of Chicago. She was a National Science Foundation Graduate Research Fellow and a published author on several scientific communications.